SpaceX Joins Nasdaq 100; Crinetics Pharmaceuticals Soars on Buyout | Stock Movers
On this episode of Stock Movers: - Fiserv (FISV) is climbing as the Wall Street Journal reports big banks including JPMorgan Chase, Bank of America, Wells Fargo and PNC Financial Services Group have held preliminary discussions about a deal to acquire a network owned by the financial-technology company Fiserv. - Crinetics Pharmaceuticals (CRNC) is soaring after Vertex Pharmaceuticals agreed to buy Crinetics for $10 billion in cash to expand into endocrinology. - SpaceX (SPCX) is lower even though at least six brokers, including Morgan Stanley and Goldman Sachs, have started coverage of SpaceX with buy-equivalent ratings. SpaceX's addition to the Nasdaq 100 should provide considerable support to the stock, considering the number of funds that track the tech-heavy benchmark.
_1434820_640x360_2505830467610-640x360.webp&w=3840&q=75)
_1434739_640x360_2505820227632-640x360.webp&w=3840&q=75)
_1434736_640x360_2505822275822-640x360.webp&w=3840&q=75)
_1434633_640x360_2505818179782-640x360.webp&w=3840&q=75)
_1434567_640x360_2505815619587-640x360.webp&w=3840&q=75)

_1434434_640x360_2505808963833-640x360.webp&w=3840&q=75)
_1434426_640x360_2505808963743-640x360.webp&w=3840&q=75)
_1434422_640x360_2505807427861-640x360.webp&w=3840&q=75)
_1434406_640x360_2505803843646-640x360.webp&w=3840&q=75)